Entry |
|
Name |
Ibrolipim (USAN/INN) |
Formula |
C19H20BrN2O4P
|
Exact mass |
450.0344
|
Mol weight |
451.25
|
Structure |
|
Efficacy |
Anti-atherosclerotic, Antidiabetic, Antidyslipidemia, Antiobesity, Lipoprotein lipase (LPL) activator |
Comment |
Antiatherogenic, Antiobesity, Antidyslipidemia, Anticachexia, And antidiabetes/syndrome X
|
Target |
|
Pathway |
|
Brite |
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Carboxylic-ester hydrolases
LPL
D03747 Ibrolipim (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 27
1 C8x C 3.9200 -17.0100
2 C8y C 3.9200 -15.6100
3 C8x C 5.1100 -14.9100
4 C8y C 6.3700 -15.6100
5 C8y C 6.3700 -17.0100
6 C8x C 5.1100 -17.7100
7 N1b N 7.5600 -17.7100
8 C5a C 8.8200 -17.0100
9 C8y C 10.0100 -17.7100
10 C8x C 11.2000 -17.0100
11 C8x C 12.4600 -17.7100
12 C8y C 12.4600 -19.1100
13 C8x C 11.2000 -19.8100
14 C8x C 10.0100 -19.1100
15 C1b C 13.6500 -19.8100
16 O5a O 8.8200 -15.6100
17 C3b C 7.5600 -14.9100
18 N3a N 8.8200 -14.2100
19 X Br 2.7300 -14.9100
20 P1b P 14.8681 -19.1199
21 O2b O 16.0805 -18.4199
22 O2b O 15.5516 -20.3156
23 O3b O 14.1622 -17.8850
24 C1b C 16.9516 -20.3156
25 C1a C 17.6419 -21.5113
26 C1b C 17.3031 -19.1259
27 C1a C 18.5125 -18.4278
BOND 28
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 1
10 9 10 2
11 10 11 1
12 11 12 2
13 12 13 1
14 13 14 2
15 9 14 1
16 12 15 1
17 8 16 2
18 4 17 1
19 17 18 3
20 2 19 1
21 15 20 1
22 20 21 1
23 20 22 1
24 20 23 2
25 22 24 1
26 24 25 1
27 21 26 1
28 26 27 1
|